Beginning in 2026, members will pay 25% coinsurance for obesity medications. This change was made because the state’s overall use of these medications and the cost to cover them continues to rise significantly. As more people begin treatment and drug prices remain high, the plan adjusted the cost share to help manage long-term sustainability.
Why did the cost for my obesity medication go up starting January 1, 2026?
